Search results
Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition
Benzinga via Yahoo Finance· 2 years agoPfizer Inc (NYSE: PFE) announced that an interim futility analysis of the global Phase 3 trial,...
Why Array Technologies, Inc. (ARRY) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 5 months agoFor new and old investors, taking full advantage of the stock market and investing with confidence...
Pfizer (PFE) Gets FDA Acceptance for Braftovi + Mektovi sNDAs
Zacks via Yahoo Finance· 1 year agoPfizer PFE announced that the FDA has accepted its supplemental new drug applications (sNDAs)...
Kinnate Biopharma (KNTE) Falls 40% in a Month: Here's Why
Zacks via Yahoo Finance· 8 months agoKinnate Biopharma (KNTE) plunges 40% in a month for the decision to streamline its pipeline to one...
FDA Approves Pfizer's (PFE) Braftovi + Mektovi for Lung Cancer
Zacks via Yahoo Finance· 7 months agoPfizer PFE announced that the FDA had approved its supplemental new drug applications (sNDAs)...
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Associated Press via Yahoo News· 1 year agoPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor...
3 Undervalued Dividend Growth Stocks
InvestorPlace via Yahoo Finance· 2 years agoInvestors focusing on a strategy of dividend growth stocks have performed better than some broader market indices. For instance, the Dividend Aristocrats...
The 7 Best Dividend Stocks to Buy in March 2023
InvestorPlace via Yahoo Finance· 1 year agoInvestors should hold dividend stocks in their portfolios. In fact, in times of volatility, these are some of the safest stocks to own for healthy cash...
